SCHEDULE: Disciplined Growth Investors Boosts Core Labs Stake

Sentiment:

Beneficial Ownership Report


Disciplined Growth Investors, Inc. has reported an 11.6% beneficial ownership stake in Core Laboratories Inc., holding 5,440,884 common shares.

Summary

  • Disciplined Growth Investors, Inc., an investment adviser based in Minneapolis, MN, has filed an Amendment No. 3 to Schedule 13G regarding its beneficial ownership in Core Laboratories Inc. /DE/.
  • The filing indicates beneficial ownership of 5,440,884 common shares of Core Laboratories Inc., representing 11.6% of the class.
  • Disciplined Growth Investors holds sole voting power over 4,942,266 shares and sole dispositive power over all 5,440,884 shares.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 8

Explanation: The filing indicates a substantial and continued institutional investment by a reputable investment adviser, which is generally perceived as a strong positive signal of confidence in the company's value and future prospects.

Positives

  • A significant 11.6% beneficial ownership by an institutional investment adviser, Disciplined Growth Investors, signals strong confidence in Core Laboratories Inc.
  • The filing is an Amendment No. 3, suggesting a continued or increased long-term interest and commitment from a major institutional investor.

Future Outlook

NA

Industry Context

This Schedule 13G filing indicates a significant institutional investment in Core Laboratories Inc. by Disciplined Growth Investors, an investment adviser. Such filings are common disclosures for large shareholders and often signal a vote of confidence from professional money managers in a company's long-term prospects within its industry.

Stakeholder Impact

  • Shareholders may view the significant and continued institutional ownership by Disciplined Growth Investors as a positive indicator of the company's stability and long-term investment appeal.

Key Dates

DateDescription
06/30/2025Date of event which requires filing of this statement
08/14/2025Signature date of the filing

Recommendation

buy

The significant and continued beneficial ownership by an investment adviser like Disciplined Growth Investors, holding over 11% of the common shares, signals strong institutional confidence in Core Laboratories Inc.'s long-term prospects and valuation, making it an attractive consideration for investment.

Keywords

Core Laboratories, CLB, Disciplined Growth Investors, institutional ownership, beneficial ownership, Schedule 13G, investment adviser, common shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.